INDIAN BENCHMARKS slump after FDA bans US imports from 2 plants
INDIAN EQUITY BENCHMARKS fell to its lowest closing level in nearly two and a half months on Wednesday as caution ahead of the expiry of monthly derivatives and the end of the fiscal year hit blue-chips. The S&P BSE Sensex and CNX Nifty ended 0.18%-0.14% lower each.
·SBI expects credit growth to pick up to 15% in FY16.
·Sun Pharma-Ranbaxy merger completed.
·Rolta India enters into MoU with Hitachi India.
The crucial resistance for Nifty is now seen at 8635 and above this 8695. Support for the immediate term is now placed at 8490 and next support will be 8435.
Get real time advice for Equity Trading Tips , Stock Cash Premium Tips , Equity Intraday Tips , Stock Cash Intraday , Stock Trading Tips , NSE Stock Market Tips and all market updates. For 2 Days Free Trial , please visit our site http://www.capitalstars.com Call at 0731-6790000, 6669900.
0 comments:
Post a Comment